This is the authors' abstract. We don't add key points for this paper.
High-dose liquid antibiotics are uncommon in bone cement. We present a case series of patients in which up to 16 mL of liquid amikacin (250 mg mL −1 ) was successfully incorporated into bone cement to treat periprosthetic joint infections. We did not observe adverse drug reactions definitively attributed to its use.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: